The atrial fibrillation (AF) device market is poised for sustained and accelerated expansion over the coming decade, driven by demographic shifts, technological breakthroughs, and evolving treatment paradigms in cardiovascular care. As atrial fibrillation remains one of the most common cardiac rhythm disorders worldwide, the demand for effective diagnostic, monitoring, and...